PBMs, insurers restrict Ozempic, Wegovy, weight loss drug access
Payers have taken a cautious approach to handling rising demand for the pricey new class of drugs known as glucagon-like peptide agnostics, or GLP-1s.
Source: modernhealthcare.com
Stay updated with breaking news from Tim Norfleet. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Payers have taken a cautious approach to handling rising demand for the pricey new class of drugs known as glucagon-like peptide agnostics, or GLP-1s.
Oregon Trail Academy works to improve pathways for success for online students, Local News, Sandy local News, Breaking News alerts for Sandy city.